Synergy Diagnostics Voted as Excellence Innovators in Blood & Biological Products!!!

We are getting great response from all 20 categories of 3rd Annual Pharmaceutical Leadership Awards being presented by PharmaLeaders, an international bi-monthly magazine & Indo-American Chamber of Commerce in association with The Times of India & ET NOW will host 3rd Annual Pharmaceutical Leadership Summit on 25th & 26th of June 2010 at Hotel Intercontinental, Mumbai, India. The two day summit will have many deliberations from industry stalwarts from Pharmaceutical, life science, bio-technology industry. More than 70 Leaders will be present to address &
deliberate the most vital & burning issues the Industry is confronting.

You can vote at pharmaleaders@pharmaleaders.co.in or sms SD( SYNERGY DIAGNOSTICS) to ++ 91 9892108169). Please see live all Nominations at www.pharmaleaders.co.in

THE GREAT INNOVATORS : SYNERGY DIAGNOSTICS

1. Synergy Diagnostics Pvt. Ltd. won the India Leadership Conclave Award as ‘UPCOMMING BIOPHARMA COMPANY 2009′

This award was presented in September 2009 at New Delhi.

1. Synergy Diagnostics Pvt. Ltd. is collaborated towards a long- term business association with Kedrion Biopharmaceuticals, Italy for marketing their biopharmaceutical products in India.
2. Synergy Diagnostics Pvt. Ltd. has helped prevent ORGAN REJECTION and MORBIDITY to a greater extent with its Anti- Cyto-megalo virus Immuneglobulin in India for ORGAN TRANSPLANTATION CASES.

This product is made available by Synergy through HUMAN BIOPLAZMA LLC, Hungary.

1. Synergy Diagnostics Pvt. Ltd. successfully completes Phase III clinical trials of its Purified Vero Cell Rabies Vaccine in India.
2. Synergy Diagnostics Pvt. Ltd. enters Neutraceutical business collaborations with Aim Pharmacon, Inc., USA.
3. Synergy Diagnostics Pvt. Ltd. has helped to prevent mortality due to rabies to a greater extent with its unique Human Rabies Immune Globulin Injection- KamRAB, for passive prophylaxis in rabies.

Injection KamRAB is the only Human Rabies Immune Globulin in India.

1. Synergy Diagnostics Pvt. Ltd. introduces Alpha-1 Anti- trypsin, manufactured by Kamada Ltd., Israel in the Indian bio-therapeutic market.

This is the only product available in India for genetic Alpha-1 Anti-trypsin deficiency in COPD patients.

1. Synergy Diagnostics Pvt. Ltd. forms a subsidiary ‘Vacc-Syn Biotech Pvt. Ltd.’ for manufacturing life saving biopharmaceuticals from the equine and rabbit serum.
2. Synergy Diagnostics Pvt. Ltd. completes pilot manufacturing plans for its Anti-Thymocyte Globulin from the rabbit serum, a unique product which will be manufactured in India. The same will be available for marketing in domestic market by IInd Quarter 2011.
3. Synergy Diagnostics Pvt. Ltd. enters business collaborations to market Anti-Gas Gangrene Serum (AGGS) in India.

AGGS will be a unique product of its kind in India which will be available only through Synergy.

1. Synergy Diagnostics Pvt. Ltd. has entered business collaborations to market a unique product, NERVE GROWTH FACTOR (mNGF) in India.

mNGF will be imported from the manufacturing company which has won the Noble Prize Award for the product.

Short URL: http://readit.in/?p=12520